Stock market week-in-review for 5 large GI companies — July 24-28

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 24 to July 28.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $250.24 on July 24
Peaked: $256.61 on July 26
Closed: $253.07 on July 28
Percent change between July 24 and July 28: 1.13 percent

2. Exact Sciences Corp.

Opened: $38.94 on July 24
Peaked: $41.96 on July 26
Closed: $39.45 on July 28
Percent change between July 24 and July 28: 2.5 percent

3. Johnson & Johnson

Opened: $134.53 on July 24
Peaked at open
Closed: $131.84 on July 24
Percent change between July 24 and July 28: -1.9 percent

4. Synergy Pharmaceuticals

Opened: $4.25 on July 24
Peaked: $4.32 on July 24
Closed: $4.06 on July 28
Percent change between July 24 and July 28: -4.4 percent

5. Valeant Pharmaceuticals

Opened: $17.51 on July 24
Peaked: $18.09 on July 25
Closed: $16.84 on July 28
Percent change between July 24 and July 28: -3.8 percent

More articles on gastroenterology:
GI leader to know: Dr. Jessica Fisher of Asheville Gastroenterology Associates
GI center to know: Asheville Gastroenterology Associates
Boston Scientific Q2 sales hit $2.25B — 4 insights

 

Advertisement

Next Up in GI & Endoscopy

  • As colonoscopy demand rises, driven in part by more diagnostic referrals for patients under 55, GI leaders are also seeing…

  • Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines.  ConMed’s gastroenterology segment is projected…

Advertisement

Comments are closed.